![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 46, 42774-42781, November 16, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Mast cell tryptase is stored as an active
tetramer in complex with heparin in mast cell secretory granules.
Previously, we demonstrated the dependence on heparin for the
activation/tetramer formation of a recombinant tryptase. Here we
have investigated the structural requirements for this activation
process. The ability of heparin-related saccharides to activate a
recombinant murine tryptase, mouse mast cell protease-6 (mMCP-6), was
strongly dependent on anionic charge density and size. The
dose-response curve for heparin-induced mMCP-6 activation displayed a
bell-shaped appearance, indicating that heparin acts by binding to more
than one tryptase monomer simultaneously. The minimal heparin
oligosaccharide required for binding to mMCP-6 was 8-10 saccharide
units. Gel filtration analyses showed that such short oligosaccharides
were unable to generate tryptase tetramers, but instead gave rise to
active mMCP-6 monomers. The active monomers were inhibited by bovine
pancreatic trypsin inhibitor, whereas the tetramers were resistant.
Furthermore, monomeric (but not tetrameric) mMCP-6 degraded
fibronectin. Our results suggest a model for tryptase tetramer
formation that involves bridging of tryptase monomers by heparin or
other highly sulfated polysaccharides of sufficient chain length.
Moreover, our results raise the possibility that some of the reported
activities of tryptase may be related to active tryptase monomers that
may be formed according to the mechanism described here.
Structural Requirements and Mechanism for Heparin-induced
Activation of a Recombinant Mouse Mast Cell Tryptase, Mouse Mast Cell
Protease-6
FORMATION OF ACTIVE TRYPTASE MONOMERS IN THE PRESENCE OF LOW
MOLECULAR WEIGHT HEPARIN*
,
¶
Department of Veterinary Medical Chemistry,
Swedish University of Agricultural Sciences, and the
§ Department of Medical Biochemistry and Microbiology,
Uppsala University, S-751 23 Uppsala, Sweden
*
This work was supported by Swedish Medical Research Council
Grants 9913 and 10354 and by grants from Glycoconjugates in Biological Systems (Swedish Foundation for Strategic Research), Vårdalstiftelsen, the Magnus Bergvalls Foundation, and King Gustaf V's 80th Anniversary Fund.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
D. Caglic, J. R. Pungercar, G. Pejler, V. Turk, and B. Turk Glycosaminoglycans Facilitate Procathepsin B Activation through Disruption of Propeptide-Mature Enzyme Interactions J. Biol. Chem., November 9, 2007; 282(45): 33076 - 33085. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hallgren, S. Backstrom, S. Estrada, M. Thuveson, and G. Pejler Histidines Are Critical for Heparin-Dependent Activation of Mast Cell Tryptase J. Immunol., August 1, 2004; 173(3): 1868 - 1875. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Gong, P. Jemth, M. L. E. Galvis, I. Vlodavsky, A. Horner, U. Lindahl, and J.-p. Li Processing of Macromolecular Heparin by Heparanase J. Biol. Chem., September 12, 2003; 278(37): 35152 - 35158. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Fajardo and G. Pejler Human Mast Cell {beta}-Tryptase Is a Gelatinase J. Immunol., August 1, 2003; 171(3): 1493 - 1499. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |